Inventor
NICOLINI VALERIA G
CH16 patents
⚠️ This page may combine multiple inventors who share the name “NICOLINI VALERIA G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE GLYCART AG
9 patentsUS10184009B2Jan 22, 2019
Mutant interleukin-2 polypeptides
ROCHE GLYCART AG37 citations97
US9526797B2Dec 27, 2016
Combination IL-2 immunoconjugate therapy
ROCHE GLYCART AG57 citations97
US10577429B2Mar 3, 2020
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG17 citations94
US10323098B2Jun 18, 2019
Mutant interleukin-2 polypeptides
ROCHE GLYCART AG25 citations94
US10253110B2Apr 9, 2019
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG15 citations94
US11332545B2May 17, 2022
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG6 citations86
US10603360B2Mar 31, 2020
Combination IL-2 immunoconjugate therapy
ROCHE GLYCART AG13 citations85
US11111312B2Sep 7, 2021
Mutant interleukin-2 polypeptides
ROCHE GLYCART AG8 citations84
US12286486B2Apr 29, 2025
Anti-FAP antibodies and methods of use
ROCHE GLYCART AG0 citations62
HOFFMANN LA ROCHE
5 patentsUS11672858B2Jun 13, 2023
Bispecific antibody molecules binding to CD3 and TYRP-1
HOFFMANN LA ROCHE2 citations72
US11591397B2Feb 28, 2023
Bispecific antibody molecules binding to CD3 and EGFRvIII
HOFFMANN LA ROCHE2 citations72
US11413331B2Aug 16, 2022
Immunoconjugates
HOFFMANN LA ROCHE4 citations71
US12473373B2Nov 18, 2025
Bispecific antibody molecules binding to CD3 and EGFRvIII
HOFFMANN LA ROCHE0 citations61
US12023368B2Jul 2, 2024
Immunoconjugates
HOFFMANN LA ROCHE1 citations60